Jennifer M. Kirk - 02 Aug 2024 Form 4 Insider Report for Medtronic plc (MDT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Aug 2024, 18:12:14 UTC
Prior SEC filing
31 Jul 2024
Next SEC filing
02 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas L. Osteraas, attorney-in-fact

Key filing fact

Jennifer M. Kirk filed Form 4 for Medtronic plc (MDT) on 06 Aug 2024.

Key facts

  • This page summarizes Jennifer M. Kirk's Form 4 filing for Medtronic plc (MDT).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Aug 2024, 18:12.

Change

  • Previous filing in this sequence was filed on 31 Jul 2024.
  • Current net transaction value: -$38,799.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Options Exercise

Transaction value
$0
Shares
+1,138
Change %
+4.1%
Price
$0.000000
Shares after
28,980
Date
02 Aug 2024
Ownership
Direct
Footnotes
F1
MDT transaction

Ordinary Shares

Tax liability

Transaction value
$7,499
Shares
-92
Change %
-0.32%
Price
$81.51
Shares after
28,888
Date
02 Aug 2024
Ownership
Direct
Footnotes
F2
MDT transaction

Ordinary Shares

Tax liability

Transaction value
$31,300
Shares
-384
Change %
-1.3%
Price
$81.51
Shares after
28,504
Date
02 Aug 2024
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Units

Options Exercise

Transaction value
$0
Shares
-1,138
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Aug 2024
Ownership
Direct
Underlying class
Performance Share Units
Underlying amount
1,138
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents, of which 910 shares will be delivered to the reporting person when her employment with the Company ends.

Footnote F2

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

Footnote F3

Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

Footnote F4

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F5

The performance share units vested on August 2, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .